Noa Memory is a digital therapeutic platform that transforms personal memories into daily cognitive training exercises to help preserve memory and generate digital biomarkers. The app combines artificial intelligence, neuroscience, and reminiscence therapy to create personalized brain-health workouts, while providing clinicians with interoperable, longitudinal data for early detection of cognitive decline.
Funding
Funding not disclosed
Founders
Product
Problem
Mild cognitive impairment and dementia-related conditions are often detected too late for early intervention, and traditional cognitive assessments require in-clinic visits that are infrequent and subjective. There is a lack of accessible, continuous tools for monitoring cognitive health in daily life, leaving families and clinicians without objective data to track decline or response to treatment.
Solution
Noa Memory provides a mobile application that converts users' personal memories into daily cognitive training exercises, making memory care as natural as using a messaging app. The platform uses artificial intelligence and neuroscience-backed methods to deliver personalized reminiscence-based workouts that stimulate cognitive function. Each session generates continuous digital biomarkers, which are measured longitudinally to track cognitive performance over time. The platform is designed for both individual users and clinical researchers, with data exportable in HL7 FHIR R4 format for seamless integration with hospital systems. Noa Memory also maps its outputs to 27 ICD-10-CM codes, including G31.84 for mild cognitive impairment and G30.x for Alzheimer's disease, enabling clinically meaningful analysis.
Target Audience
Primary users are older adults concerned about memory decline and their family caregivers, as well as clinical researchers and healthcare professionals seeking validated digital biomarkers for cognitive health studies.
Features
- AI-driven cognitive training that uses personal photos and memories as stimuli for daily brain exercises
- Continuous digital biomarker panel measured in each session, enabling longitudinal tracking of cognitive performance
- HL7 FHIR R4 interoperability for exporting data to any hospital or electronic health record system
- Mapping to 27 ICD-10-CM codes, including G31.84 (mild cognitive impairment) and G30.x (Alzheimer's disease), plus CPT 97129 for cognitive therapy
- Reminiscence-based methodology supported by public research on cognitive activity delaying dementia onset by up to 5 years
- Free-to-use mobile app available on iOS and Android, designed for daily engagement